- Home
- VSME vs PALI Comparison
VSME vs PALI Comparison
Compare VSME & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSME
- PALI
- Stock Information
- Founded
- VSME 2013
- PALI 1996
- Country
- VSME Hong Kong
- PALI United States
- Employees
- VSME N/A
- PALI N/A
- Industry
- VSME
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VSME
- PALI Health Care
- Exchange
- VSME Nasdaq
- PALI Nasdaq
- Market Cap
- VSME 4.2M
- PALI 3.5M
- IPO Year
- VSME 2023
- PALI N/A
- Fundamental
- Price
- VSME $1.16
- PALI $2.52
- Analyst Decision
- VSME
- PALI Strong Buy
- Analyst Count
- VSME 0
- PALI 1
- Target Price
- VSME N/A
- PALI $8.00
- AVG Volume (30 Days)
- VSME 476.4K
- PALI 198.8K
- Earning Date
- VSME 11-26-2024
- PALI 11-12-2024
- Dividend Yield
- VSME N/A
- PALI N/A
- EPS Growth
- VSME N/A
- PALI N/A
- EPS
- VSME N/A
- PALI N/A
- Revenue
- VSME $7,991,103.00
- PALI N/A
- Revenue This Year
- VSME N/A
- PALI N/A
- Revenue Next Year
- VSME N/A
- PALI N/A
- P/E Ratio
- VSME N/A
- PALI N/A
- Revenue Growth
- VSME N/A
- PALI N/A
- 52 Week Low
- VSME $0.65
- PALI $2.18
- 52 Week High
- VSME $6.26
- PALI $22.35
- Technical
- Relative Strength Index (RSI)
- VSME 44.45
- PALI 38.02
- Support Level
- VSME $1.10
- PALI $2.20
- Resistance Level
- VSME $1.62
- PALI $2.71
- Average True Range (ATR)
- VSME 0.21
- PALI 0.31
- MACD
- VSME -0.05
- PALI -0.03
- Stochastic Oscillator
- VSME 23.33
- PALI 25.76
About VSME VS Media Holdings Limited
VS Media Holdings Ltd manages a global network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fanbases on social media platforms. The company's business provides value to two major business stakeholders: Creators and Brands. Its Value to Creators: It empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content. Its Value to Brands: the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content strategy and budget and recommending specific Creators.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.